Progesterone.

Vitex acts on dopamine D2 receptors in the pituitary and lowers prolactin release, part of what sets luteal-phase progesterone output. It works upstream on the signal rather than supplying the hormone.

Progesterone and DHEA are formed from pregnenolone down the delta-4 and delta-5 branches respectively. Supplying one does not top up the other, so formulas wanting both carry both.

Diosgenin from wild yam is the laboratory starting material for semi-synthetic progesterone, and the human body has no enzyme that performs that conversion. A wild yam preparation does not deliver progesterone unless progesterone has been added.

St. John's Wort is a strong inducer of CYP3A4, the enzyme family that metabolises progesterone. Co-use lowers circulating progesterone exposure from the same dose.

Pyridoxal-5-phosphate is the cofactor for the decarboxylase that makes dopamine, and dopamine tone restrains pituitary prolactin release. That places B6 on the same upstream lever vitex acts on.

Steroid hormones are conjugated to glucuronide for excretion, and gut beta-glucuronidase can cleave that bond and return them to circulation. Calcium D-glucarate inhibits that enzyme, shifting how conjugated steroids are cleared.

Cholesterol is cleaved to pregnenolone by CYP11A1 inside the mitochondrion, then 3-beta-HSD oxidises and isomerises pregnenolone to progesterone. That single enzymatic step is the whole relationship. Supplying the precursor does not control where the steroid pathway goes next, since progesterone itself branches toward several downstream steroids.

Progesterone is practically insoluble in water, so oral preparations suspend micronized drug substance in oil and are taken with food. Lipid in the lumen drives micelle formation and lymphatic uptake, which is why fasting and fed exposure differ substantially. The pairing is formulation chemistry, not an added activity.

Lecithin stabilises the emulsion in a cream or an oil suspension and improves spread and contact at the application site. Its role is physical, holding the steroid in a deliverable state. Nothing about the emulsifier changes what the hormone does once absorbed.

Oral progesterone undergoes heavy first-pass metabolism through CYP3A4 with glucuronidation of its reduced metabolites. Piperine inhibits both systems in laboratory and animal work, so co-administration could raise exposure to an amount that was never dosed for. This is a reason to flag the combination, not a reason to use it.

Glucuronidation is the dominant exit route for pregnanolone and pregnanediol metabolites. Silybin inhibits UGT enzymes in vitro at concentrations that are not always reached in people. Flag the pairing as a plausible clearance interaction with laboratory grounding only.

Oral progesterone is well known for drowsiness, which traces to allopregnanolone acting at the same receptor family engaged by other sedating compounds. Melatonin works on a different receptor system but the subjective result overlaps. Timing both at night is the usual practice and morning grogginess is the thing to watch.

Allopregnanolone, the reduced metabolite of progesterone, is one of the strongest endogenous positive modulators of GABA-A. Adding a botanical with GABAergic activity stacks on the same receptor. Sedation is the additive endpoint to expect and to plan around.

Apigenin has measurable affinity at GABA-A benzodiazepine sites in binding assays. Progesterone reaches the same receptor complex through its neuroactive metabolite. The overlap is receptor-level and the human evidence for the combination is absent.

L-theanine shifts EEG alpha activity and is used for calm without a hypnotic effect. Progesterone brings sedation through allopregnanolone at GABA-A. Stacking them is a plausible additive effect on alertness rather than a documented interaction.

Cholesterol side chain cleavage to pregnenolone happens on the inner mitochondrial membrane and needs a working electron transfer chain through ferredoxin and ferredoxin reductase. Coenzyme Q10 is a carrier in the respiratory chain that supports that compartment's function. The connection is upstream and mechanistic, with no combination trial.

Steroidogenic cells hold some of the highest ascorbate concentrations in the body, and ascorbate is released during acute stimulation of those tissues. The cytochrome P450 steps of steroid synthesis generate reactive oxygen species that ascorbate helps contain. This describes the tissue biochemistry rather than an effect of supplementation on hormone levels.

The luteal phase is regulated in part by prostaglandin signalling built from arachidonic acid. EPA competes with arachidonic acid for cyclooxygenase and shifts the series of prostaglandins produced. The step is well characterised biochemically; what it means for hormone levels in people is not settled.

The DNA binding domain of every nuclear receptor in this family is built on two zinc-coordinating fingers, so structural zinc is required for the receptor to contact its response element. That requirement is structural biology, not a dosing claim. Adding zinc above requirement does not amplify receptor signalling.

Magnesium blocks the NMDA channel pore and dampens excitatory transmission, which is why it is used at night. Progesterone brings its own sedation through allopregnanolone at GABA-A. Different receptors, similar direction, so expect the effects to add on subjective alertness.

Licorice raises mineralocorticoid receptor activation by letting cortisol reach the receptor unconverted, which pushes toward sodium retention. Progesterone occupies the same receptor as an antagonist and tends to push the other way. The two act at one receptor from opposite directions, which makes the combination worth flagging rather than ignoring.

DIM shifts oestradiol metabolism toward 2-hydroxy metabolites through CYP1A1 induction. Because endometrial progesterone receptor expression is itself driven by oestrogen, changing the oestrogen picture changes the receptor context progesterone acts in. The interaction is indirect and the human data are limited.

Inositol phosphates transmit signal from FSH and LH receptors inside ovarian cells, and luteinising hormone is the main stimulus for luteal progesterone production. Supplementation studies in this space report changes in ovulatory measures rather than in progesterone directly. Read the link as upstream signalling.

Small supplementation studies report shifts in oestradiol and testosterone with boron, with a proposed effect on steroid hormone clearance or binding. The measurements are hormone levels, which are markers, and the studies are small. No specific effect on progesterone is established.

Both adrenal corticosteroids and gonadal progestogens are built from pregnenolone by the same early enzymes. Ashwagandha trials report lower cortisol measures, which is a marker change. Any downstream consequence for progesterone is inference, not a finding.